ClaimShield methodology & limits

A transparent description of the current automated screen

What the screen does

ClaimShield applies a finite set of text rules to the copy and product type you submit. The rules look for possible disease-claim language, drug implications, selected substantiation phrases, and possible dietary-supplement label/labeling disclaimer review points. Matches are screening signals for human review.

Each current rule category links directly to the official FDA, FTC, or eCFR material used for orientation, with a source-review date. The 0–100 value is a heuristic prioritization score, not a probability of illegality, deception, enforcement, or consumer harm.

What it does not establish

  • It does not decide whether copy is lawful or compliant.
  • It does not evaluate study quality, formulation, dose, audience, disclosures, images, page context, or every express and implied message.
  • It does not cover every federal, state, local, or international requirement.
  • It cannot infer whether submitted copy is a label, labeling, an advertisement, or another communication. That distinction can change which requirements apply.
  • FDA says wording and the complete labeling context determine whether a statement is a disease claim; a keyword match is not an agency determination.
  • The DSHEA disclaimer review signal is limited to possible dietary-supplement structure/function statements. FTC guidance says that disclaimer is not generally required in other advertising and cannot cure an otherwise deceptive claim.
  • A short citation in a result is an orientation aid, not an agency finding or legal opinion.

Lower-risk drafts are editing suggestions, not compliant copy or permission to publish. Qualified counsel and relevant subject-matter experts should review the complete claim, evidence, and context.

Primary references for human review

These links are authoritative starting points, but FDA and FTC guidance does not itself decide a particular case and applicable law can change. Review the current source text and obtain advice for the specific product, evidence, medium, audience, and jurisdiction.

Methodology reviewed September 5, 2026.